SELLAS Life Sciences Group Inc’s recent filing unveils that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported $14800.0 on Jun 12 ’25. In the deal valued at $1.48 per share,10,000 shares were bought. As a result of this transaction, VAN NOSTRAND ROBERT L now holds 20,400 shares worth roughly $33864.0.
Then, Wasman Jane bought 20,000 shares, generating $33,800 in total proceeds. Upon buying the shares at $1.69, the Director now owns 30,400 shares.
Before that, Kalin Katherine Bach bought 20,000 shares. SELLAS Life Sciences Group Inc shares valued at $36,000 were divested by the Director at a price of $1.80 per share. As a result of the transaction, Kalin Katherine Bach now holds 41,000 shares, worth roughly $68060.0.
Cantor Fitzgerald initiated its SELLAS Life Sciences Group Inc [SLS] rating to an Overweight in a research note published on July 21, 2021; the price target was $18. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early November with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering SLS with “Buy” recommendation on April 02, 2018. Maxim Group revised its rating on March 19, 2018. It rated SLS as “a Buy” which previously was an “a Hold”.
Price Performance Review of SLS
On Friday, SELLAS Life Sciences Group Inc [NASDAQ:SLS] saw its stock jump 0.61% to $1.66. Over the last five days, the stock has gained 3.11%. SELLAS Life Sciences Group Inc shares have risen nearly 59.62% since the year began. Nevertheless, the stocks have risen 16.90% over the past one year. While a 52-week high of $2.12 was reached on 05/27/25, a 52-week low of $0.77 was recorded on 01/23/25.
Levels Of Support And Resistance For SLS Stock
The 24-hour chart illustrates a support level at 1.6167, which if violated will result in even more drops to 1.5733. On the upside, there is a resistance level at 1.7167. A further resistance level may holdings at 1.7733.
How much short interest is there in SELLAS Life Sciences Group Inc?
A steep rise in short interest was recorded in SELLAS Life Sciences Group Inc stocks on 2025-05-30, growing by 4.51 million shares to a total of 12.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 7.71 million shares. There was a rise of 36.92%, which implies that there is a positive sentiment for the stock.
